Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Lethal snake viruses identified
Inclusion Body Disease affects constrictor snakes

A study has identified the cause of a fatal illness that affects captive snakes.

Inclusion Body Disease (IBD) is a condition which affects constrictor snakes, such as boas and pythons, and hitherto its cause has been uncertain. There is no treatment for the illness - for which symptoms include 'star-gazing', breathing problems and general muscular paralysis - and its cause has always been suspected to be a virus.

Now, in research published in the open-access journal mBio, scientists have analysed samples obtained from snakes with IBD and found genetic material that closely resembles that present in viruses belonging to the arenaviruses family.

The researchers were also able to grow the virus from samples taken from one of the snakes.

Dr Mark Stenglein co-led the study. He commented: "We don't yet have formal evidence that these viruses cause the disease… although there is a good correlation [between disease and the presence of virus] … it is also possible that other viruses or pathogens cause a similar set of symptoms".

As of yet the disease seems to be restricted to captive snakes, but there is concern that the release of captive snakes could unleash the virus into the wild. 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.